Koolen M I, Daha M R, Frölich M, Van Es L A, Van Brummelen P
Eur J Clin Invest. 1984 Jun;14(3):171-4. doi: 10.1111/j.1365-2362.1984.tb01118.x.
The relevance of age and activity of the renin-angiotensin-aldosterone system to the excretion of urinary kallikrein (Ukal) was studied in twenty-five patients with essential hypertension and forty normotensive controls. The age range for both study groups was 20-60 years. Ukal was measured by radioimmunoassay and by an amidolytic assay. Results of both assays correlated closely (r = 0.93, n = 65, P less than 0.001). For all hypertensives Ukal excretion was not significantly different from that of controls. However, older hypertensives (greater than 40 years, n = 13) had a significantly lower Ukal excretion than normotensives of the same age (n = 20) (radioimmunoassay 67.2 (SEM 7.2) v. 105.1 (SEM 8.4) micrograms (24 h)-1; and amidolytic method 0.84 (SEM 0.10) v. 1.13 (SEM 0.08) U (24 h)-1). No correlation was found between Ukal excretion and plasma renin or aldosterone. In fact, the aldosterone level was highest in older hypertensives. In conclusion, the lower Ukal excretion in hypertensives over 40 is likely to be secondary to the long-standing high blood pressure. Under basal conditions, Ukal excretion seems little influenced by the activity of the renin-angiotensin-aldosterone system.
在25例原发性高血压患者和40例血压正常的对照者中,研究了肾素 - 血管紧张素 - 醛固酮系统的年龄和活性与尿激肽释放酶(Ukal)排泄的相关性。两个研究组的年龄范围均为20 - 60岁。通过放射免疫测定法和酰胺水解测定法测量Ukal。两种测定结果密切相关(r = 0.93,n = 65,P < 0.001)。对于所有高血压患者,Ukal排泄与对照组无显著差异。然而,年龄较大的高血压患者(大于40岁,n = 13)的Ukal排泄明显低于同年龄的血压正常者(n = 20)(放射免疫测定法:67.2(标准误7.2)对105.1(标准误8.4)微克(24小时)-1;酰胺水解法:0.84(标准误0.10)对1.13(标准误0.08)U(24小时)-1)。未发现Ukal排泄与血浆肾素或醛固酮之间存在相关性。事实上,年龄较大的高血压患者醛固酮水平最高。总之,40岁以上高血压患者Ukal排泄较低可能是长期高血压的继发结果。在基础条件下,Ukal排泄似乎很少受肾素 - 血管紧张素 - 醛固酮系统活性的影响。